Addition of rubidomycin to induction treatment with vincristine, prednisone, and L-asparaginase in standard-risk childhood acute lymphocytic leukemia (study ALL V): a report on behalf of the Dutch Childhood Leukemia Study Group.
van der Does-van den Berg
A
A
van Wering
E R
ER
de Koning
J
J
Rammeloo
J A
JA
Solbu
G
G
Suciu
S
S
van Zanen
G E
GE
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D002986:Clinical Trials as Topic; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D009426:Netherlands; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin